Clicky

Codexis, Inc.(CDXS)

Description: Codexis, Inc. engages in the production of custom industrial enzymes for use in the pharmaceutical, biofuel, and chemical production. The company offers Codex Biocatalyst Panels and Kits to pharmaceutical companies that are engaged in drug development and the marketing of approved drugs to allow them to screen and identify possible enzymatic manufacturing processes for their drug candidates and their marketed products. It also provides enzyme screening, enzyme optimization, and enzyme services, as well as supplies intermediates and active pharmaceutical ingredients to pharmaceutical companies. In addition, the company develops CodeXyme cellulase enzymes to convert cellulosic biomass, a non-food plant material into affordable sugars, which could then be converted into renewable fuels and chemicals; and CodeXol detergent alcohols used to manufacture surfactants, which are used as cleaning ingredients in consumer products, such as shampoos, liquid soaps, and laundry detergents. It intends to market CodeXyme cellulase enzymes to chemicals manufacturers; and CodeXol detergent alcohols as a drop-in substitute for the detergent alcohols market. The company has collaboration with Purolite Corporation to develop and market enzymes for the pharmaceutical industry. Codexis, Inc. was founded in 2002 and is headquartered in Redwood City, California.


Keywords: Chemical Pharmaceutical Consumer Products Chemical Product Active Pharmaceutical Ingredients Biofuel Telemedicine Telehealth Alcohol Cellulose Drug Development Biomass Manufacturing Process Enzymes Shampoo Catalysis Renewable Fuels Detergent Surfactant Manufacturing Processes Laundry Detergent Chemical Production Cellulase

Home Page: www.codexis.com

CDXS Technical Analysis

200 Penobscot Drive
Redwood City, CA 94063
United States
Phone: 650 421 8100


Officers

Name Title
Dr. Stephen George Dilly MBBS, Ph.D. Pres, CEO & Director
Mr. Ross Taylor Jr., M.B.A. Sr. VP & CFO
Mr. John J. Nicols Director & Strategic Advisor
Mr. Kevin Norrett M.B.A., M.S. Chief Operating Officer
Ms. Margaret Fitzgerald J.D. Chief Legal and Compliance Officer, Gen. Counsel & Sec.
Ms. Asli Aras Ph.D. VP & Head of Corp. Devel.
Ms. Karen Frechou-Armijo Sr. VP & Head of HR
Mr. Rob Wilson Ph.D. Sr. VP & GM of Performance Enzymes
Dr. Karl A. Schoene Ph.D. Sr. VP of Devel. & Operations
Dr. Stefan Lutz Ph.D. Sr. VP of Research

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 138.8889
Trailing PE: 0
Price-to-Book MRQ: 2.3781
Price-to-Sales TTM: 2.7321
IPO Date: 2010-04-22
Fiscal Year End: December
Full Time Employees: 261
Back to stocks